Motilal Oswal Mutual Fund

Motilal Oswal BSE Healthcare ETF-Growth

Equity: Sectoral-Pharma - Growth (Open ended)Download Report
SEBI Riskometer: Very HighCategory: Equity: Sectoral-PharmaBenchmark: BSE Healthcare Total Return IndexCheck Portfolio Overlap →
₹54.28+0.62%
20 Nov 2026

Similar ETFs

Side-by-side comparison of Motilal Oswal BSE Healthcare ETF-Growth with similar ETFs — tracking error, returns, AUM and expense ratio.
PeriodThis FundCategory AvgCategory Rank
1Y Return+19.71%19.81%14 / 29
3Y Return+21.96%21.01%6 / 19
5Y Return—15.94%—
10Y Return—14.83%—

Trailing annualised returns (%). Category rank: lower is better. Green = top third of category.

Please login to continue

Frequently Asked Questions

Which ETFs are similar to Motilal Oswal BSE Healthcare ETF-Growth?
ETFs similar to Motilal Oswal BSE Healthcare ETF-Growth in the Equity: Sectoral-Pharma category include Nippon India Nifty Pharma ETF-Growth, ICICI Prudential Nifty Healthcare ETF-Growth, and Groww BSE Hospitals ETF-Growth. These ETFs follow a comparable investment mandate and are benchmarked against similar indices. You can compare them in detail — across returns, risk metrics, expense ratio, and portfolio composition — using the ETF comparison tool on sharpely.
What is the rank of Motilal Oswal BSE Healthcare ETF-Growth in its category?
On a 3-year return basis Motilal Oswal BSE Healthcare ETF-Growth is ranked 6 out of 19 ETFs in the Equity: Sectoral-Pharma category as of 19 Nov 2026. Consistently ranking in the top across multiple time periods is a stronger signal of ETF quality than a single-period rank.
How does Motilal Oswal BSE Healthcare ETF-Growth's expense ratio compare to similar ETFs?
Motilal Oswal BSE Healthcare ETF-Growth has an expense ratio of 0.34%. The peers Nippon India Nifty Pharma ETF-Growth has an expense ratio of 0.23% and ICICI Prudential Nifty Healthcare ETF-Growth has 0.18%. Over the long term, a higher expense ratio can meaningfully drag on returns, so it is worth evaluating whether the ETF's performance justifies the additional cost.
How does Motilal Oswal BSE Healthcare ETF-Growth's AUM compare to similar ETFs?
Motilal Oswal BSE Healthcare ETF-Growth has an AUM of ₹44.5 crore. The peers Nippon India Nifty Pharma ETF-Growth has an AUM of ₹1,756.56 crore and ICICI Prudential Nifty Healthcare ETF-Growth has ₹240.11 crore. A large AUM can sometimes limit a ETF's ability to take meaningful positions in mid and small-cap stocks, as larger trades can move prices. This is particularly relevant for ETFs that invest outside large caps.
Which ETF has the best 3-year returns in the Equity: Sectoral-Pharma?
The top performing ETF in the Equity: Sectoral-Pharma category on a 3-year basis is Nippon India Nifty Pharma ETF-Growth with a CAGR of 22.02% as of 19 Nov 2026. Motilal Oswal BSE Healthcare ETF-Growth has delivered 21.96% CAGR over the same period, ranking 6 out of 19 ETFs. You can view and compare the full category ranking on sharpely.
How does Motilal Oswal BSE Healthcare ETF-Growth rank in risk-adjusted returns vs peers?
On a risk-adjusted basis, Motilal Oswal BSE Healthcare ETF-Growth has a Sharpe ratio of 1.02 compared to the Equity: Sectoral-Pharma average of 0.98 as of 19 Nov 2026. It ranks 2 out of 5 ETFs in its category on Sharpe ratio.